Improving Medicaid Precision and Cancer Test Act of 2025

# Improving Medicaid Precision and Cancer Test Act of 2025 (HR 6320) ## What the Bill Would Do This bill aims to improve how Medicaid covers precision medicine tests and cancer diagnostic tests. Precision medicine uses genetic and other biological information to tailor treatments to individual patients, while cancer tests help detect and diagnose cancer. The bill would likely establish clearer coverage rules and standards for these types of medical tests under Medicaid, the federal health insurance program for low-income Americans. ## Who It Affects and Current Status The bill primarily affects Medicaid beneficiaries (low-income individuals and families enrolled in Medicaid) and healthcare providers who order or conduct these tests.

It could also impact state Medicaid programs, which share administration of the program with the federal government. As of now, the bill is in committee, meaning it has not yet been debated or voted on by the full House of Representatives. Without detailed legislative text available, the specific provisions—such as which tests would be covered or how coverage would be determined—cannot be detailed further.